Molecule to Market: Inside the outsourcing space

May 03 2024 30
Molecule to Market: Inside the outsourcing space Podcast artwork

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Zero to a billion... A CDMO original - part 2

May 03 2024 54 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector for part 2 of our conversation with Thomas Eldered, Executive Chairman at Flerie. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: The story behind Recipharm’s decision to divest Cobra Biologics that led T

Zero to a billion... A CDMO original - part 1

Apr 26 2024 64 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with part 1 of our episode with Thomas Eldered, Executive Chairman at Flerie. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: Where his entrepreneurial spark originated, and how they created a CMO (before t

Dan’s the man...at Custom Biologics

Apr 19 2024 49 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dan Mamelak, Founder & President at Custom Biologics. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dan, covering: How reading The Billion-dollar Molecule book inspired him to explore a pathway into cutting-edge d

Celebrating female talent in life sciences

Apr 05 2024 20 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Denise Bowser from Onyx Scientific Audrey Greenberg from SK Pharmteco Kendalle Burlin O’Connell from MassBio Elisabeth Stampa from Medicines For Europe Sabina Ouimet-Storrs from GHO Capital In this episode, we feature highlights from recent interviews with s

The power of peptides

Mar 28 2024 45 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alastair Hay, Vice President of Peptides at Almac Sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Alastair, covering: The story behind Almac’s early bet of getting into the peptide game Behind the scenes of

From Pfizer to CDMO carve-out

Mar 22 2024 49 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Brett Alderson, President and Site Leader of Novacina. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Brett, covering: The complexities of being on the inside of big pharma looking to carve out your site... then transi

One-hour special: Meet the next big thing in obesity

Mar 15 2024 66 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Arvid Söderhall, CEO at Empros Pharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Arvid, covering: The personal story of a pediatrician treating an obese child that led to the creation of Empros Pharma and its lea

M&A Roundtable and 2024 Predictions

Mar 08 2024 57 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Sabina Ouimet-Storrs, Principal at GHO Capital Partners James West, Managing Director at Lincoln International Derek Hennecke, investor and board member in biopharma and cell therapy manufacturing Your host, Raman Sehgal, discusses the pharmaceutical and biote

Transforming a family pharma firm

Mar 01 2024 43 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Elisabeth Stampa, President Medicines for Europe and Board Chair at Medichem. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Elisabeth, covering: She took the reigns of the family pharmaceutical firm from her father Th

From MassBio... to the world

Feb 23 2024 55 mins  
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kendalle Burlin O’Connell, CEO and President of MassBio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kendalle, covering: The story behind how Massachusetts became one of the biggest biotech clusters in the world a